Reviews Kapidex Delayed Release Capsules


No reviews yet.

Kapidex Delayed Release Capsules Drug Description
Kapidex (Now known as Dexilant)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION



What are the possible side effects of dexlansoprazole (Kapidex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

chest pain, fast or pounding heartbeats;
severe stomach pain; or
worsening heartburn.

Less serious side effects may include:

nausea, vomiting, stomach pain, gas;
diarrhea; or
stuffy...
Read All Potential Side Effects for Kapidex Delayed Release Capsules »




The active ingredient in KAPIDEX (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl} sulfinyl]-1H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S,
with a molecular weight of 369.36. The structural formula is:








Dexlansoprazole is a white to nearly white crystalline powder which melts with
decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide,
methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile;
slightly soluble in ether; and very slightly soluble in water; and practically
insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable
in neutral and alkaline conditions than acidic conditions.
KAPIDEX is supplied as a dual delayed release formulation in capsules for oral
administration. The capsules contain dexlansoprazole in a mixture of two types
of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
KAPIDEX is available in two dosage strengths: 30 mg and 60 mg, per capsule.
Each capsule contains enteric-coated granules consisting of dexlansoprazole
(active ingredient) and the following inactive ingredients: sugar spheres, magnesium
carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide,
hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymer,
polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon
dioxide. The components of the capsule shell include the following inactive
ingredients: hypromellose, carrageenan and potassium chloride. Based on the
capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray
contains ferric oxide and aluminum lake; and both contain titanium dioxide.
Last reviewed on RxList: 4/14/2010




Kapidex Delayed Release Capsules Drug Description
Kapidex (Now known as Dexilant)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION



What are the possible side effects of dexlansoprazole (Kapidex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

chest pain, fast or pounding heartbeats;
severe stomach pain; or
worsening heartburn.

Less serious side effects may include:

nausea, vomiting, stomach pain, gas;
diarrhea; or
stuffy...
Read All Potential Side Effects for Kapidex Delayed Release Capsules »




The active ingredient in KAPIDEX (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl} sulfinyl]-1H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S,
with a molecular weight of 369.36. The structural formula is:








Dexlansoprazole is a white to nearly white crystalline powder which melts with
decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide,
methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile;
slightly soluble in ether; and very slightly soluble in water; and practically
insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable
in neutral and alkaline conditions than acidic conditions.
KAPIDEX is supplied as a dual delayed release formulation in capsules for oral
administration. The capsules contain dexlansoprazole in a mixture of two types
of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
KAPIDEX is available in two dosage strengths: 30 mg and 60 mg, per capsule.
Each capsule contains enteric-coated granules consisting of dexlansoprazole
(active ingredient) and the following inactive ingredients: sugar spheres, magnesium
carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide,
hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymer,
polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon
dioxide. The components of the capsule shell include the following inactive
ingredients: hypromellose, carrageenan and potassium chloride. Based on the
capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray
contains ferric oxide and aluminum lake; and both contain titanium dioxide.
Last reviewed on RxList: 4/14/2010




Kapidex Delayed Release Capsules Drug Description
Kapidex (Now known as Dexilant)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION



What are the possible side effects of dexlansoprazole (Kapidex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

chest pain, fast or pounding heartbeats;
severe stomach pain; or
worsening heartburn.

Less serious side effects may include:

nausea, vomiting, stomach pain, gas;
diarrhea; or
stuffy...
Read All Potential Side Effects for Kapidex Delayed Release Capsules »




The active ingredient in KAPIDEX (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl} sulfinyl]-1H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S,
with a molecular weight of 369.36. The structural formula is:








Dexlansoprazole is a white to nearly white crystalline powder which melts with
decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide,
methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile;
slightly soluble in ether; and very slightly soluble in water; and practically
insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable
in neutral and alkaline conditions than acidic conditions.
KAPIDEX is supplied as a dual delayed release formulation in capsules for oral
administration. The capsules contain dexlansoprazole in a mixture of two types
of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
KAPIDEX is available in two dosage strengths: 30 mg and 60 mg, per capsule.
Each capsule contains enteric-coated granules consisting of dexlansoprazole
(active ingredient) and the following inactive ingredients: sugar spheres, magnesium
carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide,
hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymer,
polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon
dioxide. The components of the capsule shell include the following inactive
ingredients: hypromellose, carrageenan and potassium chloride. Based on the
capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray
contains ferric oxide and aluminum lake; and both contain titanium dioxide.
Last reviewed on RxList: 4/14/2010




Kapidex Delayed Release Capsules Drug Description
Kapidex (Now known as Dexilant)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION



What are the possible side effects of dexlansoprazole (Kapidex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

chest pain, fast or pounding heartbeats;
severe stomach pain; or
worsening heartburn.

Less serious side effects may include:

nausea, vomiting, stomach pain, gas;
diarrhea; or
stuffy...
Read All Potential Side Effects for Kapidex Delayed Release Capsules »




The active ingredient in KAPIDEX (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl} sulfinyl]-1H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S,
with a molecular weight of 369.36. The structural formula is:








Dexlansoprazole is a white to nearly white crystalline powder which melts with
decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide,
methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile;
slightly soluble in ether; and very slightly soluble in water; and practically
insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable
in neutral and alkaline conditions than acidic conditions.
KAPIDEX is supplied as a dual delayed release formulation in capsules for oral
administration. The capsules contain dexlansoprazole in a mixture of two types
of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
KAPIDEX is available in two dosage strengths: 30 mg and 60 mg, per capsule.
Each capsule contains enteric-coated granules consisting of dexlansoprazole
(active ingredient) and the following inactive ingredients: sugar spheres, magnesium
carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide,
hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymer,
polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon
dioxide. The components of the capsule shell include the following inactive
ingredients: hypromellose, carrageenan and potassium chloride. Based on the
capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray
contains ferric oxide and aluminum lake; and both contain titanium dioxide.
Last reviewed on RxList: 4/14/2010




Kapidex Delayed Release Capsules Drug Description
Kapidex (Now known as Dexilant)
(dexlansoprazole) Delayed Release Capsules
DRUG DESCRIPTION



What are the possible side effects of dexlansoprazole (Kapidex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

chest pain, fast or pounding heartbeats;
severe stomach pain; or
worsening heartburn.

Less serious side effects may include:

nausea, vomiting, stomach pain, gas;
diarrhea; or
stuffy...
Read All Potential Side Effects for Kapidex Delayed Release Capsules »




The active ingredient in KAPIDEX (dexlansoprazole) delayed release capsules
is (+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl} sulfinyl]-1H-benzimidazole,
a compound that inhibits gastric acid secretion. Dexlansoprazole is the R-enantiomer
of lansoprazole (a racemic mixture of the R- and S-enantiomers). Its empirical
formula is: C16H14F3N3O2S,
with a molecular weight of 369.36. The structural formula is:








Dexlansoprazole is a white to nearly white crystalline powder which melts with
decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide,
methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile;
slightly soluble in ether; and very slightly soluble in water; and practically
insoluble in hexane.
Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable
in neutral and alkaline conditions than acidic conditions.
KAPIDEX is supplied as a dual delayed release formulation in capsules for oral
administration. The capsules contain dexlansoprazole in a mixture of two types
of enteric-coated granules with different pH-dependent dissolution profiles
[see CLINICAL PHARMACOLOGY].
KAPIDEX is available in two dosage strengths: 30 mg and 60 mg, per capsule.
Each capsule contains enteric-coated granules consisting of dexlansoprazole
(active ingredient) and the following inactive ingredients: sugar spheres, magnesium
carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide,
hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymer,
polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon
dioxide. The components of the capsule shell include the following inactive
ingredients: hypromellose, carrageenan and potassium chloride. Based on the
capsule shell color, blue contains FD&C Blue No. 2 and aluminum lake; gray
contains ferric oxide and aluminum lake; and both contain titanium dioxide.
Last reviewed on RxList: 4/14/2010





Other reviews about Kapidex Delayed Release Capsules on wordpress

FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules For The Treatment Of GERD
  by maciekmaciek5
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX™ (dexlansoprazole) delayed release […]


FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules For The Treatment Of GERD
  by maciekmaciek5
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX™ (dexlansoprazole) delayed release […]


Israeli Peace Effort
  by siluansa
In some fashion, that is Mr. Netanyahu’s own claim — that only someone like himself, with hawkish credentials, can and will produce lasting peace because only such a […]


His voice was less harsh and
  by mvwbivabwsyvu
Smith laughed at them; but they insisted on loading a ship with the worthless stuff and sending it to London. It was beginning to rain again, and altogether […]


cartoon: Man falls into outhouse h
  by qkysrszzlqsrsbv
Oh, Albert, of course they will. And I MADE him horridI know I did! Behind that thought were generations of men and women who had sacrificed and suffered […]


But he was the one wh
  by djvvisjzvjkpcj
We cant be moren four hundred miles from the Yukon, concluded Sloper, multiplying his thumb nails by the scale of the map. Hes t gentleman this journey. Colonel […]


But theyre so small they
  by evcrutqefpzcrzj
The light from her candle fell faintly behind her. 11:15 And if thou deal thus with me, kill me, I pray thee, out of hand, if I have […]



Other reviews about Kapidex Delayed Release Capsules on web:

Learn about the prescription medication Kapidex Delayed Release Capsules (Dexlansoprazole Delayed Release Capsules), drug uses, dosage, side effects, drug interactions ... Kapidex Delayed Release Capsules (Dexlansoprazole Delayed Release ...


All about Kapidex Delayed-Release Capsules. View complete and up to date Kapidex information - part of the Drugs.com trusted medication database. Kapidex Delayed-Release Capsules Facts and Comparisons at Drugs.com


Kapidex Capsule, Delayed Release - Healing of Erosive EsophagitisKAPIDEX is indicated for healing of all grades of erosive esophagitis (EE) for up to 8 weeks. Maintenance of ... Kapidex Capsule, Delayed Release drug information | MIMS USA


Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA ... FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules ...


FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD First proton pump inhibitor (PPI) with a Dual Delayed Release(TM) (DDR ... FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release ...


Osaka, Japan, January 31,2009 and Deerfield, Ill., January 30, 2009 – – Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North ... FDA Approves KAPIDEX™ (dexlansoprazole) delayed release capsules ...


Deerfield, Ill. – February 23, 2009 – Takeda Pharmaceuticals North America, Inc. today announced that KAPIDEX™ (dexlansoprazole) delayed release capsules are now available in ... KAPIDEX™ (dexlansoprazole) delayed release capsules Now ...


KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD DEERFIELD, Ill., Feb. 23 /PRNewswire/ -- Takeda Pharmaceuticals North ... KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now ...


Your prescription for actionable health and medication news. FDA Approves Kapidex Delayed-release Capsules for GERD | www ...


Prescription DEXILANT capsules are used in adults to treat heartburn related ... DEXILANT, KAPIDEX, and Dual Delayed Release are trademarks of Takeda Pharmaceuticals North America ... Welcome to the Official Site of DEXILANT™ (dexlansoprazole)





Featured Reviews

Reviews Sevelamer Carbonate

Renvela Drug Description Renvela® (sevelamer carbonate) Tablets Renvela® (sevelamer carbonate) For Oral Suspension DRUG DESCRIPTION What are the possible side effects of sevelamer (Renagel, Renvela)? Get emergency medical...
Read More  |  Review This
Reviews Sulfamylon Cream

Sulfamylon Cream Drug Description SULFAMYLON® Cream (mafenide acetate) Cream, USP Topical Antibacterial Agent for Adjunctive Therapy In Second- and Third-Degree Burns DRUG DESCRIPTION What are the possible side effects of mafenide...
Read More  |  Review This
Reviews Asacol

Asacol Drug Description Asacol® (mesalamine) Delayed-Release Tablets DRUG DESCRIPTION What are the possible side effects of mesalamine oral (Apriso, Asacol, Lialda, Pentasa)? Get emergency medical help if you have any...
Read More  |  Review This
Reviews Hytrin

Hytrin Drug Description HYTRIN® (terazosin hydrochloride) DRUG DESCRIPTION What are the possible side effects of terazosin (Hytrin)? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Piperacillin and Tazobactam Injection

Zosyn Drug Description Zosyn® (piperacillin and tazobactam) Injection To reduce the development of drug-resistant bacteria and maintain the effectiveness of Zosyn (piperacillin and tazobactam) injection and other antibacterial drugs, ...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....